Home | List of Topics | Cancer | Hematology
PCH is a rare blood disorder caused when a person is exposed to the cold, and the immune system makes proteins called antibodies that destroy red blood cells.
Paroxysmal cold hemoglobinuria only occurs in the cold, and affects mainly the hands and feet. Antibodies are formed that attack one type of blood cell. These antibodies attach (bind) to red blood cells and to proteins in the blood (called complements) that destroy cells. The blood cells are destroyed when they move through the body and get rewarmed. As the cells are destroyed, the part of red blood cells, called hemoglobin, which carries oxygen is released into the blood and passed in the urine.
The disease has been linked to secondary syphilis, tertiary syphilis, and other infections (diseases caused by viruses or bacteria). Sometimes the cause is unknown.
People with this disease often get better quickly and do not have symptoms between episodes. Usually, the attacks end as soon as the affected cells stop moving through the body. The risk factors are infection with a virus and syphilis. The disorder is rare.
The disease that caused the disorder can be treated. Sometimes, treatment that decreases the immune system (immunosuppressive therapy) is used. Cases caused by syphilis get better when the syphilis is treated.
Many cases will get better without treatment. In some people, the attacks may happen many times over the years.
Call your health care provider if you have symptoms of this disorder. The doctor can rule out other causes of the symptoms and decide whether you need treatment.
People who know they have this disease can prevent future attacks by staying out of the cold.
Ferri FF. Ferri's Clinical Advisor 2007. 1st ed. Philadelphia, Pa: Mosby; 2006.
Hoffman R, Benz E, Shattil S, Furie B, Cohen H. Hematology: Basic Principles and Practice. 4th ed. Philadelphia, Pa: Churchill Livingstone; 2004.
Roddr EG, Hillmen P, Schreiber AD. Immune-mediated hemolytic anemia. Hematology Am Soc Hematol Educ Program. January 2004;48-62.
Review Date:3/13/2007
Reviewed By:Mark Levin, MD, Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.